×
Back to Agenda
TOPIC 5 SESSION 5: Effectiveness of Risk Minimisation Measures
Session Chair(s)
Gaby L. Danan, MD, PhD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Effectiveness of Risk Minimisation Measures
Jan Petracek, MD, MSc
iVigee Services a.s., Czech Republic
CEO
Have an account?